Foghorn Therapeutics (FHTX) Free Cash Flow Growth (1y) (2020 - 2026)
Foghorn Therapeutics (FHTX) Free Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 1,092.51% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Foghorn Therapeutics | 351.87 Mn | 262.96 Mn | - | -5.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.29% |
| Dec 31, 2025 | 10.91% |
| Sep 30, 2025 | 11.51% |
| Jun 30, 2025 | 17.93% |
| Mar 31, 2025 | 18.51% |
| Dec 31, 2024 | 12.92% |
| Sep 30, 2024 | 21.58% |
| Jun 30, 2024 | 20.05% |
| Mar 31, 2024 | 6.46% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | -38.83% |
| Jun 30, 2023 | -8.81% |
| Mar 31, 2023 | -111.60% |
| Dec 31, 2022 | -294.87% |
| Sep 30, 2022 | 5.56% |
| Jun 30, 2022 | -43.11% |
| Mar 31, 2022 | 1,225.39% |
| Dec 31, 2021 | 439.83% |
| Sep 30, 2021 | -668.14% |
| Jun 30, 2021 | -42.62% |